Elevance Health/ELV
$547.71
0.7%-
1D1W1MYTD1YMAX
About Elevance Health
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
Ticker
ELV
Sector
Healthcare
Trading on
NYSE
Industry
Insurance (Accident & Health)
CEO
Gail Boudreaux
Employees
104,900
Headquarters
Indianapolis, United States
Website
www.elevancehealth.com
Elevance Health Metrics
BasicAdvanced
$126B
Market cap
20.40
P/E ratio
$26.47
EPS
0.83
Beta
$6.07
Dividend rate
1.21%
Dividend yield
Price and volume
Market cap
$126B
Beta
0.83295
52-week high
$543.13
52-week low
$412.00
Average daily volume
962K
Dividend rate
$6.07
Financial strength
Long term debt to equity
54.117
Total debt to equity
65.137
Dividend payout ratio (TTM)
22.93%
Interest coverage (TTM)
9.42%
Management effectiveness
Return on assets (TTM)
5.65%
Return on equity (TTM)
16.02%
Valuation
Price to earnings (TTM)
20.403
Price to revenue (TTM)
0.731
Price to book
3.092
Price to tangible book (TTM)
31.765
Price to free cash flow (TTM)
143.761
Five year average dividend yield
1.09%
Dividend yield (TTM)
1.12%
Forward dividend yield
1.21%
Growth
Revenue change (TTM)
6.89%
Earnings per share change (TTM)
4.91%
3-year revenue growth
12.03%
3-year earnings per share growth
11.94%
3-year dividend per share growth
15.93%
What the Analysts think about Elevance Health
Analyst Ratings
Majority rating from 22 analysts.
Price Targets
Average projection from 17 analysts.
High $665.00
Low $558.00
$547.71
Current price
$605.45
Average price target
Elevance Health Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$43B
-0.16%
Net income
$2.2B
162.38%
Profit margin
5.27%
163.5%
Elevance Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$9.04
$8.99
$5.62
$10.64
-
Expected
$8.80
$8.44
$5.64
$10.53
$10.02
Surprise
2.77%
6.52%
-0.41%
1.03%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $127B as of May 20, 2024.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 20.69 as of May 20, 2024.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $6.07 and the yield is 1.19%. Elevance Health has a payout ratio of 22.93% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment is scheduled for June 25, 2024.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Elevance Health stock price target?
The target price for Elevance Health (ELV) stock is $605.45, which is 10.54% above the current price of $547.71. This is an average based on projections from 17 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Elevance Health stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.